Press Release May 29, 2019

Goodwin Extends Global Life Sciences Practice to Asia with Partner Wendy Pan

高赢任命潘文森 (Wendy Pan) 为合伙人 , 将 全 球 生 命 科 学 业 务 扩 展 至 亚 洲

Global law firm Goodwin announced today that Dr. Wenseng “Wendy” Pan has joined its Life Sciences practice as a partner in the Hong Kong office.

Pan regularly advises Chinese, U.S. and multinational life sciences and technology companies, as well as venture and private equity firms in structuring and negotiating mergers and acquisitions, private and public investments, and complex IP-based transactions. She is active in the U.S.-China life sciences community and is a recognized deal maker and opinion leader.

“China is well on its way to becoming the second-largest biotech market in the world next to the United States. In addition, the  Hong Kong stock exchange has become an attractive market for many global biotech companies to consider for their public offerings, and Chinese investors are a significant capital source for biotech companies around the world,” said Mitchell Bloom, Chair of Goodwin’s Life Sciences practice. “Our Life Sciences team is focused on advising our clients on both their China-focused and cross-border matters and Wendy’s extensive experience and leadership will be invaluable as we continue to build on our life sciences capabilities in China and globally.”

“Bringing Wendy on board reflects Goodwin’s commitment to continuing our growth in Greater China,” said Yash Rana, Chair of Goodwin’s Hong Kong office. “Wendy is among the few go-to lawyers for life sciences deals in China, and we are thrilled that she has chosen to join the Goodwin platform.”

Pan received a J.D. and a PhD in Chemistry from Columbia University, and an undergraduate degree from Fudan University. She is registered to practice in the State of New York and before the U.S. Patent & Trademark Office, and is a registered foreign lawyer in Hong Kong.

Pan can be reached at wpan@goodwinlaw.com and +852.3658.5362.

Goodwin represents leading public and private life sciences companies across their entire life cycles – including financings, capital market transactions, mergers and acquisitions, collaborations and licensing, intellectual property and regulatory matters. Goodwin has been named life sciences “Practice Group of the Year” by Law360, “Biotech Firm of the Year” by U.S. News and World Report - Best Lawyers for five years, and “IP Law Firm of the Year” and “Life Cycle Firm of the Year” by LMG Life Sciences. In 2018, Goodwin advised issuers on more than a dozen biotechnology and pharmaceutical industry IPOs worth in aggregate nearly $2 billion — making Goodwin the number one advisor in this sector by offering value. This work included representation of Moderna Therapeutics in the largest biotechnology IPO in history.

Lawyers in Goodwin’s Hong Kong office focus on serving clients across the private equity, life sciences, technology, financial services and real estate industries throughout Asia. The office, which was established in 2008, recently celebrated its ten-year anniversary.

香港 -- (美国商业资讯)-- 跨国律师事务所 高赢 (Goodwin) 今天宣布, 潘文森 (Wenseng “ Wendy ” Pan) 博士 已加入其 生命科学业务团队,担任 香港 办事处合伙人。

 律师主要就并购、公私投资和 涉及 复杂 知识产权  交易的安排和协商,为中国、美国及跨国生命科学和科技公司,以及创投公司和私募股权公司提供相关咨询。她活跃于中美生命科学界, 擅长 促成 交易,也是位 公认  意见领袖。

高赢生命科学业务 主管 Mitchell Bloom 表示:「中国正逐步成为仅次于美国的世界第二大生物科技市场。此外,香港交易所已经成为极具吸引力的市场,许多全球生物科技公司纷纷考虑在香港进行公开募股,而中国投资者是全球生物科技公司的重要资金来源。我们的生命科学团队专注于就中国及跨境问题向客户提供咨询服务,随着我们继续加强本事务所在中国乃至全球生命科学领域的服务能力, Wendy 丰富的经验和出色的领导能力  我们 将是非常宝贵的 。」

高赢香港办事处主席 荣雅士 (Yash Rana) 表示:「 Wendy 的加盟反映出高赢力求在大中华市场持续成长的决心。Wendy 是中国生命科学交易领域少有的顶尖律师之一,她选择加入高赢平台,我们感到非常高兴。」

 律师 拥有哥 伦比亚大学的法学博士和化学博士学位,以及复旦大学的本科学位。 她具有 纽约州和美国专利商标局注册执业 资格 ,还是香港的注册外国律师。

    律师 联系  可发送电邮至 wpan@goodwinlaw.com 或致电 +852.3658.5362 

高赢为一流的上市及私有生命科学公司代理案件,涵盖客户的整个生命周期,包括融资、资本市场交易、并购、合作与授权、智  产权和监管事务。 高赢曾荣获Law360 生命科学「年度最佳执业团队」、曾五年荣获 US News and World Report - Best Lawyers 「年度最佳生物科技事务所」,以及荣获 LMG Life Sciences 「年度最佳 IP 律师事务所」和「年度最佳生命周期律师事务所」称号。 2018 年,高赢就十多个生物科技和制药业 IPO 向发行者提供咨询,总价值近 20 亿美元 —— 这令高赢成为该领域以募股价值计排名第一的 律师事务所  这其中包括在有史以来最大的生物科技 IPO 中担任 Moderna Therapeutics  法律顾问 

高赢香港办事处的律师专注于为亚洲私募股权、生命科学、科技、金融服务和房地产业的客户提供服务。 该办事处于 2008 年设立,最近刚庆祝成立十 周年 

   

在高赢,我们本着诚信、创造性、灵活性和宏伟抱负,与客户合作开展法律业务。 我们遍布美国、欧洲和亚洲的 1,000 多名律师精通各种复杂的交易、 大型 的诉讼和世界级的咨询服务,涵盖科技、生命科学、房地产、私募股权和金融等行业。 在信息万变、技术驱动的新经济体中,高赢与众不同之处,是具备同时为创新者和投资者提供服务的经验。